Skip to content

Integrated Biopharma Inc

INBP· OTCCore metricsCIK 1016504

Pharmaceutical preparations553 peers

Close
Jun 6, 2025 · +15.38%
Market cap
$9.09M
30.3M shares
Filings
559
$9.91M
Q1 2027−19.3% FY26 yoy
-$691.00K
Q1 2027N/M FY26 yoy
-$961.00K
Q1 2027N/M FY26 yoy
-$1.34M
Q1 2027derived−52.2% FY26 yoy
-$0.02
Q1 2027N/M FY26 yoy
$3.12M
Q1 2027+23.7% FY26 yoy
$9.09M
—
0.2×
0.5×
-17.34%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.30+36.36%+$0.08past year
Jun 6, 2025 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$43.87MFY 2026
$63.56M0FY 2015FY 2020FY 2026
PeriodEndedValueKindSource trail
FY 20262026-06-30$43,872,000reported
FY 20252025-06-30$54,353,000reported
FY 20242024-06-30$50,317,000reported
FY 20232023-06-30$50,672,000reported
FY 20222022-06-30$56,246,000reported
FY 20212021-06-30$63,559,000reported
FY 20202020-06-30$52,769,000reported
FY 20192019-06-30$49,977,000reported
FY 20182018-06-30$43,710,000reported
FY 20172017-06-30$46,954,000reported
FY 20162016-06-30$42,214,000reported
FY 20152015-06-30$37,488,000reported

Segments

Revenue by Segments, FY2020 to FY2025FY2020Contract Manufacturing · FY2020 · $51.33MOther Nutraceutical Business · FY2020 · $1.44MFY2021Contract Manufacturing · FY2021 · $61.84MOther Nutraceutical Business · FY2021 · $1.72MFY2022Contract Manufacturing · FY2022 · $54.09MOther Nutraceutical Business · FY2022 · $2.16MFY2023Contract Manufacturing · FY2023 · $48.28MOther Nutraceutical Business · FY2023 · $2.40MFY2024Contract Manufacturing · FY2024 · $48.57MOther Nutraceutical Business · FY2024 · $1.75MFY2025Contract Manufacturing · FY2025 · $51.68MOther Nutraceutical Business · FY2025 · $2.67M
LineFY2025ShareChange
Contract Manufacturing$51.68M95%+6.4%
Other Nutraceutical Business$2.67M4.9%+52.7%
Total$54.35M

From the 10-K filed Sep 23, 2025INBP

Pharmaceutical preparations

Integrated Biopharma Inc is the 134th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Integrated Biopharma Inc · CIK 1016504 · Engraved from SEC EDGAR